SESSION CHAIR

 

Dr Dania Movia

SENIOR RESEARCH FELLOW AT TRINITY COLLEGE DUBLIN.

 
Dania is a senior scientist of the Trinity Translational Medicine Institute (TTMI) of Trinity College Dublin. She is also a lecturer in the Trinity MSc in Molecular Medicine since 2016. In her research Dania focuses on developing and using in vitro complex, tissue-mimetic models of the human lung with a specific focus on mimicking the cancer cell-stroma crosstalk found in vivo in malignant lung tumours. Within her work, Dania applies such models with the aim to increase the translation success rate of the oncological treatments.
 
Since 2017, Dania is Trinity co-Principal Investigator in the EU-funded BIORIMA project, and in 2018, she was awarded funding by the Johns Hopkins University Center for Alternatives to Animal Testing (CAAT) as principal investigator. Earlier this year she became member of the Scientific Advisory Panel of Animal Free Research UK and Expert Panel member of the SAToRI-BTR project. She also holds membership of the European Association for Cancer Research. 

KEYNOTE SPEAKER

Dr Helena Kandarova

Helena’s professional scientific interest is focusing on the development, validation and implementation of in vitro methods for reduction & replacement of in vivo tests for topical toxicity testing of chemicals, cosmetics, pesticides and medical devices. She has been involved or directly managed international projects aiming at the evaluation and validation of 3D reconstructed human tissue models replacing testing in animals.

Helena completed her PhD thesis on the „ Use of Reconstructed human tissue models in regulatory toxicology“ in 2006 at Freie Universität in Berlin. Her PhD thesis was largely supported by ZEBET at the Federal Institute of Risk Assessment (BfR). After finishing her PhD, she joined MatTek Corporation, USA in 2007 in the position of Senior Scientist and General Acting Manager for EU and since 2009 - 2018 she acted also as Exectutive Director of MatTek In Vitro Life Science Laboratories, located in the EU.   

Helena is board member of several professional toxicology platforms, associate editor at three toxicology-oriented journals and she actively contributes to in vitro toxicology and concept of 3Rs via her expert work at the OECD and at national expert platforms. She co-authored over 40 publications and achieved more than 1000 cited references. She was president of the EUROTOX 2017 Congress and obtained several awards related to in vitro toxicology and 3Rs.

The Presenters

 

Dr Pascale Guillot

Non Clinical Senior Lecturer

UCL

"Replacing the use of animals to study bone fragility"

Dr Marta Rucka

Product Manager, Cellular Analysis.

Promega, UK

"Factors to Consider for Developing In Vitro Cytotoxicity Assays to Replace Animal Testing"

Dr Jan Turner

Director

Safer Medicines Trust

"HUMAN RELEVANT IN VITRO MODELS – BARRIERS, INITIATIVES AND PROGRESS TOWARDS REPLACING ANIMAL METHODS IN DRUG DISCOVERY"

REGISTER TODAY